pyrimethamine has been researched along with propidium in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carbonari, M; De Felice, M; Gambardella, L; Giammarioli, AM; Giovannetti, A; Iacobini, M; Malorni, W; Pierdominici, M; Quinti, I | 1 |
1 other study(ies) available for pyrimethamine and propidium
Article | Year |
---|---|
Pyrimethamine (2,4-diamino-5-p-chlorophenyl-6-ethylpyrimidine) induces apoptosis of freshly isolated human T lymphocytes, bypassing CD95/Fas molecule but involving its intrinsic pathway.
Topics: Annexin A5; Apoptosis; Autoimmune Diseases; Caspase 10; Caspase 8; Caspases; Cells, Cultured; Child; Cytochromes c; Dose-Response Relationship, Drug; Enzyme Activation; fas Receptor; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Immunosuppressive Agents; Interleukin-10; Membrane Potentials; Mitochondria; Models, Biological; Propidium; Pyrimethamine; T-Lymphocytes; Treatment Outcome | 2005 |